CNS Drugs Journal Issues Research Articles in March 2024 Edition
March 21, 2024
March 21, 2024
CHAM, Switzerland, March 21 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its March 2024 edition (Vol. 38, Issue 3):
* Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data
* Comparative Efficacy and Safety of Monoclonal Antibodies for C . . .
* Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data
* Comparative Efficacy and Safety of Monoclonal Antibodies for C . . .